Literature DB >> 11849560

Lysosomal storage results in impaired survival but normal neurite outgrowth in dorsal root ganglion neurones from a mouse model of Sandhoff disease.

K Sango1, S Yamanaka, K Ajiki, A Tokashiki, K Watabe.   

Abstract

Sandhoff disease is a heritable lysosomal storage disease resulting from impaired degradation of GM2 ganglioside and related substrates. A mouse model of Sandhoff disease created by gene targeting displays progressive neurological manifestations, similar to patients with the disease. In the present in vivo and in vitro studies, we examined morphological and functional abnormalities of dorsal root ganglion (DRG) neurones in Sandhoff disease mice at an asymptomatic stage (approximately 1 month of age). Light microscopic studies with Nissl staining and immunocytochemistry suggested extensive intracytoplasmic storage of GM2 ganglioside in the Sandhoff mouse DRG neurones. These findings were consistent with the results of electron microscopy, in which a huge number of pleomorphic inclusion bodies immunoreactive for GM2 ganglioside were present in the cytoplasm of the neurones. The inclusion bodies were also identified in satellite cells and Schwann cells in the Sandhoff mouse DRG. The survival ratios of DRG neurones after 1, 2, 4 and 6 days in culture were significantly lower in the Sandhoff mice than in the age-matched heterozygous mice. The ratio of neurite-bearing cells on poly-l-lysine-coated dishes after 2 days in culture was also lower by approximately 10% in the Sandhoff mice compared to the heterozygotes, but additional coating of laminin onto poly-l-lysine dramatically enhanced the neurite extension from the neurones in both groups of mice. These results indicate that accumulation of GM2 ganglioside in DRG neurones impairs the capability of the neurones to survive in vitro, although viable neurones from the Sandhoff mice in culture can regenerate neurites nearly as well as unaffected neurones.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849560     DOI: 10.1046/j.1365-2990.2002.00366.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  10 in total

1.  DRG-targeted helper-dependent adenoviruses mediate selective gene delivery for therapeutic rescue of sensory neuronopathies in mice.

Authors:  Tomoya Terashima; Kazuhiro Oka; Angelika B Kritz; Hideto Kojima; Andrew H Baker; Lawrence Chan
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

2.  Plasmid-based gene transfer ameliorates visceral storage in a mouse model of Sandhoff disease.

Authors:  Akira Yamaguchi; Kayoko Katsuyama; Kyoko Suzuki; Kenji Kosaka; Ichiro Aoki; Shoji Yamanaka
Journal:  J Mol Med (Berl)       Date:  2003-02-12       Impact factor: 4.599

3.  Establishment of immortalized Schwann cells from Sandhoff mice and corrective effect of recombinant human beta-hexosaminidase A on the accumulated GM2 ganglioside.

Authors:  Mai Ohsawa; Masaharu Kotani; Youichi Tajima; Daisuke Tsuji; Yasuhiro Ishibashi; Aya Kuroki; Kohji Itoh; Kazuhiko Watabe; Kazunori Sango; Shoji Yamanaka; Hitoshi Sakuraba
Journal:  J Hum Genet       Date:  2005-09-23       Impact factor: 3.172

4.  Primary culture of neural cells isolated from the cerebellum of newborn and adult mucopolysaccharidosis type IIIA mice.

Authors:  L M Sutherland; K M Hemsley; J J Hopwood
Journal:  Cell Mol Neurobiol       Date:  2008-02-23       Impact factor: 5.046

5.  Possible role of autoantibodies in the pathophysiology of GM2 gangliosidoses.

Authors:  Akira Yamaguchi; Kayoko Katsuyama; Kiyotaka Nagahama; Toshiyuki Takai; Ichiro Aoki; Shoji Yamanaka
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

6.  Expression and histochemical localization of ciliary neurotrophic factor in cultured adult rat dorsal root ganglion neurons.

Authors:  Kazunori Sango; Hiroko Yanagisawa; Shizuka Takaku
Journal:  Histochem Cell Biol       Date:  2007-05-23       Impact factor: 4.304

7.  Therapeutic advantages of combined gene/cell therapy strategies in a murine model of GM2 gangliosidosis.

Authors:  Davide Sala; Francesca Ornaghi; Francesco Morena; Chiara Argentati; Manuela Valsecchi; Valeria Alberizzi; Roberta Di Guardo; Alessandra Bolino; Massimo Aureli; Sabata Martino; Angela Gritti
Journal:  Mol Ther Methods Clin Dev       Date:  2022-03-16       Impact factor: 6.698

8.  Impaired neural differentiation of induced pluripotent stem cells generated from a mouse model of Sandhoff disease.

Authors:  Yasuhiro Ogawa; Makoto Tanaka; Miho Tanabe; Toshihiro Suzuki; Tadayasu Togawa; Tomoko Fukushige; Takuro Kanekura; Hitoshi Sakuraba; Kazuhiko Oishi
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

9.  Peripheral nervous system manifestations in a Sandhoff disease mouse model: nerve conduction, myelin structure, lipid analysis.

Authors:  Melanie A McNally; Rena C Baek; Robin L Avila; Thomas N Seyfried; Gary R Strichartz; Daniel A Kirschner
Journal:  J Negat Results Biomed       Date:  2007-07-10

10.  Abnormal differentiation of Sandhoff disease model mouse-derived multipotent stem cells toward a neural lineage.

Authors:  Yasuhiro Ogawa; Katsutoshi Kaizu; Yusuke Yanagi; Subaru Takada; Hitoshi Sakuraba; Kazuhiko Oishi
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.